✦ LIBER ✦

Long-term treatment of bleeding caused by portal hypertension in children

✍ Scribed by Fernando Alvarez

Book ID: 117165617
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 308 KB
Volume: 131
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(97)70023-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term results of surgical treatment

Long-term results of surgical treatment for bleeding oesophageal varices in children with portal hypertension

✍ M. R. B. Keighley; R. W. Girdwood; G. H. Wooler; M. I. Ionescu 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 609 KB

Extrahepatic portal hypertension in chil

Extrahepatic portal hypertension in children: Long-term evaluation

✍ E.Thomas Boles Jr.; William E. Wise Jr.; Gary Birken 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 830 KB

Surgical treatment of portal hypertensio

Surgical treatment of portal hypertension—long-term results

✍ William P. Longmire Jr. 📂 Article 📅 1966 🏛 Elsevier Science 🌐 English ⚖ 711 KB

Long-term follow-up of portal hypertensi

Long-term follow-up of portal hypertension after liver transplantation in children

✍ S. C. Ling; A. Pfeiffer; Y. Avitzur; A. Fecteau; D. Grant; V. L. Ng 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Treatment of bleeding from portal hypert

Treatment of bleeding from portal hypertensive gastropathy by portacaval shunt

✍ Marshall J. Orloff; Dr Mark S. Orloff; Dr Susan L. Orloff; Kevin S. Haynes 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 945 KB

Portal hypertensive gastropathy is a vascular disorder of the gastric mucosa distinguished by ectasia of the mucosal capillaries and submucosal veins without inflammation. During 1988 to 1993,12 patients with biopsyproven cirrhosis (10 alcoholic, 2 posthepatitic) were evaluated and treated prospecti

Long-term octreotide treatment prevents

Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats

✍ C C Sieber; F Lee; R J Groszmann 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

Chronically portal-hypertensive rats show in vitro vascular hyporeactivity in large part mediated by the endothelium-derived vasodilator nitric oxide. We tested whether long-term octreotide treatment (15 micrograms/kg subcutaneously in 5% D/W, 8-hourly) corrects the in vitro vascular hyporeactivity.